Fibrosarcoma Market (線維肉腫市場) is expected to surpass USD 612.7 million by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2032. The market is estimated to be worth USD 349.9 million globally in 2022.
Fibrosarcoma, a rare soft tissue sarcoma, poses a significant challenge in the field of oncology due to its aggressive nature and limited treatment options. Despite being...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek